Graft survival and long-term renal function after sequential conventional cyclosporin a therapy in cadaver kidney transplantation — a prospective randomized trial
Authors:
- 1 September 1987
- journal article
- research article
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 65 (18) , 879-884
Abstract
In a prospective randomized trial 50 renal transplant patients (group A) received a sequential course of 14 days conventional immunosuppression (Lymphocytoglobuline (ALG), azathioprine, steroids) and cyclosporin and steroids thereafter, while 50 patients (group B) received the conventional immunosuppression for 7 days followed by cyclosporin and steroids. In the latter group ALG was tolerated for the whole period while in the first group conversion from conventional to cyclosporin A therapy had to be performed after a mean of 11 days, due to ALG intolerance. Actual patient survival rates 1 year posttransplant were 100% in both groups and graft survival rates 96% in group A and 86% in group B (PP=0.064). Serum creatinine 1 year posttransplant was 1.8±0.8 mg/dl in group A and 2.2±1.4 in group B. A total of 58 patients had a serum creatinine of less than 2 mg/dl at the time of conversion to cyclosporin. These patients had a significantly better graft survival rate (98.3%) and serum creatinine 1 year posttransplant (1.6±0.5 mg/dl) than the 40 patients with a serum creatinine of more than 2 mg/dl at the time of conversion (85%; 2.4±1.4 mg/dl), indicating that a delayed onset of cyclosporin therapy might benefit the kidney in the immediate posttransplant period when it is susceptible to nephrotoxicity due to the damage from hypothermic storage.Keywords
This publication has 23 references indexed in Scilit:
- DILTIAZEM AND ECONOMIC USE OF CYCLOSPORINThe Lancet, 1986
- A Randomized Clinical Trial of Cyclosporine in Cadaveric Renal TransplantationNew England Journal of Medicine, 1986
- Protektiver Einfluss des Calciumantagonisten Diltiazem auf das akute Nierenversagen nach Nierentransplantation: Ergebnisse einer prospektiven randomisierten StudieDMW - Deutsche Medizinische Wochenschrift, 1986
- Immunsuppression nach Nierentransplantation mit Antilymphozytenglobulin und anschließender Ciclosporin-Behandlung: Eine prospektive StudieDMW - Deutsche Medizinische Wochenschrift, 1986
- SEQUENTIAL USE OF MINNESOTA ANTILYMPHOBLAST GLOBULIN AND CYCLOSPORINE IN CADAVERIC RENAL TRANSPLANTATIONTransplantation, 1985
- Nutzen und Grenzen einer prophylaktischen Antilymphozytenglobulin-Therapie nach Nierentransplantation A prospectively randomized trialJournal of Molecular Medicine, 1984
- Cyclosporine: Five Years' Experience in Cadaveric Renal TransplantationNew England Journal of Medicine, 1984
- A Randomized Clinical Trial of Cyclosporine in Cadaveric Renal TransplantationNew England Journal of Medicine, 1983
- THE EFFECT OF CYCLOSPORINE ON EARLY GRAFT FUNCTION IN HUMAN RENAL TRANSPLANTATIONTransplantation, 1983
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958